Promoted Content
Promoted Content

Company profile for ZCL Chemicals Limited

Client EmailClient Virtual Booth
ZCL CHEMICALS LIMITED

Virtual Booth 100% Export Oriented R&D Center & cGMP facility// Broad range of advance fine chemical intermediates & APIs

ZCL Chemicals Ltd is an 100% Export Oriented Unit (EOU) that combines the power of science & technology. Established in 1991, the company head quarter is in Mumbai .The R&D Center and cGMP-manufacturing facility is in the Industrial heart of Ankleshwar city in Gujarat, 300 k.m. North of Mumbai, well connected by Road, Rail and Air enabling swift cargo movement to the nearest major sea/airport being Mumbai. The Company delivers a broad range of advance fine chemical intermediates and active.
ZCL-Chemicals-RM
ZCL Chemicals Limited
Indianew1 Flag
Country
Country
INDIA
Address
Address
Birla Aurora, 12A, Dr Annie Besant Rd, Worli, Mumbai, 400030
Telephone
Telephone
+91 22 615 39999
Twitter
Twitter
Contact Info
Others

purchase@zclchemicals.com

Email

ACCESS
YOUR PHARMACOMPASS
EXTRANET

The email can't be empty The input is not a valid email
The password can't be empty
Virtual Booth
Virtual Booth
Market Place
Market Place
Positioning
Positioning
Broadcasting
Broadcasting
Blog
Blog
Interview
Interview
Search Engine Optimization
Search Engine
Optimization
Bussiness Intelligence Reports
Bussiness Intelligence
Reports
Bussiness Development, Marketing Intelligence
Bussiness Development
Marketing Intelligence

VIRTUAL BOOTH : It is your company profile on PharmaCompass where you can list your Sales & Marketing content. Customizing your Virtual Booth costs only 125 euros/ month [12 months subscription].

Subscribe me now
Send me more info on the VIRTUAL BOOTH

MARKET PLACE : PharmaCompass’ global market place where we receive multiple requests every day for products and services. Suppliers get connected directly over email with enquirers and as PharmaCompass is not a distributor, we do not take commission on transactions. The cost of subscribing to this option starts at 1500 euros/ year.

Subscribe me now
Send me more info on the MARKET PLACE

POSITIONING : Place your advertisements on the relevant PharmaCompass pages of your key products or services, and position your company as the leader for those offerings.

Send me the different offers
Send me more info on POSITIONING

BRANDING : You can broadcast a message throughout PharmaCompass whenever you want to communicate a new Product Launch, attendance at a trade show, new Certification, etc...

Send me the different offers
Send me more info on BRANDING

INTERVIEW : Create content for your own website and distribute it on social media. Our professional journalists will guide you through questions on the topics you wish to promote

Send me the different offers
Send me more info on the INTERVIEW

BIR// BUSINESS INTELLIGENCE REPORTS :
BUSINESS INTELLIGENCE REPORTS [APIs & Finished Formulations]
Where are your customers? How can you reduce costs? What is your competition doing? Etc... We can answer pretty much any question to help your future business strategy.

Ask Us
Send me more info on the BIR

BDMI// BUSINESS DEVELOPMENT INTELLIGENCE REPORTS :
BUSINESS DEVELOPMENT INTELLIGENCE REPORTS [Excipients & Services]
Using market intelligence data, we can support your Marketing and Sales departments by highlighting new potential prospects.

Ask Us
Send me more info on the BDMI
left grey arrow
right gray arrow
  • Corporate Presentation

https://www.pharmacompass.com/pdf/party/content/zcl-chemicals-ltd-party-content-1588007697.pdf

See all info for this product

See Less

USDMF

Found

Application Number
30120
Status
Status - Active
Facility Fees - Paid
DMF Review - Complete
Filing Details
ARIPIPRAZOLE USP
Issue/Submission Date
2015-12-14
CEP/COS

Found

Application Number
Status
VALID
Filing Details
Aripiprazole
Issue/Submission Date
2018-03-08
Japanese DMF

Close

Application Number
Status
 
Filing Details
Issue/Submission Date
Written Confirmation

Found

Application Number
Indian CDSCO WC-0195
Status
Valid - 2022-07-02
Filing Details
Levomepromazine Maleate
Issue/Submission Date
2019-06-17
Application Number
30120
Indian CDSCO WC-0195
Status
Status - Active
Facility Fees - Paid
DMF Review - Complete
VALID
 
Valid - 2022-07-02
Filing Details
ARIPIPRAZOLE USP
Aripiprazole
Levomepromazine Maleate
Issue/Submission Date
2015-12-14
2018-03-08
2019-06-17
See all info for this product

See Less

USDMF

Found

Application Number
29211
Status
Status - Active
Facility Fees - Paid
DMF Review - Complete
Filing Details
ATOMOXETINE HYDROCHLORIDE USP
Issue/Submission Date
2015-03-26
CEP/COS

Found

Application Number
Status
VALID
Filing Details
Atomoxetine hydrochloride
Issue/Submission Date
2020-06-19
Japanese DMF

Close

Application Number
Status
 
Filing Details
Issue/Submission Date
Written Confirmation

Found

Application Number
Indian CDSCO WC-0195
Status
Valid - 2022-07-02
Filing Details
Atomoxetine Hydrochloride EP/USP
Issue/Submission Date
2019-06-17
Application Number
29211
Indian CDSCO WC-0195
Status
Status - Active
Facility Fees - Paid
DMF Review - Complete
VALID
 
Valid - 2022-07-02
Filing Details
ATOMOXETINE HYDROCHLORIDE USP
Atomoxetine hydrochloride
Atomoxetine Hydrochloride EP/USP
Issue/Submission Date
2015-03-26
2020-06-19
2019-06-17
See all info for this product

See Less

USDMF

Found

Application Number
31999
Status
Status - Active
Facility Fees - Paid
DMF Review - Complete
Filing Details
CLOZAPINE USP
Issue/Submission Date
2017-08-24
CEP/COS

Found

Application Number
Status
VALID
Filing Details
Clozapine
Issue/Submission Date
2020-04-02
Japanese DMF

Close

Application Number
Status
 
Filing Details
Issue/Submission Date
Written Confirmation

Found

Application Number
Indian CDSCO WC-0195
Status
Valid - 2022-07-02
Filing Details
Clozapine BP/USP/EP
Issue/Submission Date
2019-06-17
Application Number
31999
Indian CDSCO WC-0195
Status
Status - Active
Facility Fees - Paid
DMF Review - Complete
VALID
 
Valid - 2022-07-02
Filing Details
CLOZAPINE USP
Clozapine
Clozapine BP/USP/EP
Issue/Submission Date
2017-08-24
2020-04-02
2019-06-17
See all info for this product

See Less

USDMF

Found

Application Number
29582
Status
Status - Active
Facility Fees - Paid
DMF Review - Complete
Filing Details
FLUVOXAMINE MALEATE USP
Issue/Submission Date
2015-07-22
CEP/COS

Found

Application Number
Status
VALID
Filing Details
Fluvoxamine maleate
Issue/Submission Date
2020-08-31
Japanese DMF

Close

Application Number
Status
 
Filing Details
Issue/Submission Date
Written Confirmation

Found

Application Number
Indian CDSCO WC-0195
Status
Valid - 2022-07-02
Filing Details
Fluvoxamine Maleate EP/USP
Issue/Submission Date
2019-06-17
Application Number
29582
Indian CDSCO WC-0195
Status
Status - Active
Facility Fees - Paid
DMF Review - Complete
VALID
 
Valid - 2022-07-02
Filing Details
FLUVOXAMINE MALEATE USP
Fluvoxamine maleate
Fluvoxamine Maleate EP/USP
Issue/Submission Date
2015-07-22
2020-08-31
2019-06-17
See all info for this product

See Less

USDMF

Found

Application Number
32201
Status
Status - Active
Facility Fees - Paid
DMF Review - Complete
Filing Details
PIRFENIDONE
Issue/Submission Date
2017-10-28
CEP/COS

Found

Application Number
Status
VALID
Filing Details
Pirfenidone
Issue/Submission Date
2018-10-11
Japanese DMF

Close

Application Number
Status
 
Filing Details
Issue/Submission Date
Written Confirmation

Found

Application Number
Indian CDSCO WC-0195
Status
Valid - 2022-07-02
Filing Details
Pirfenidone BP/EP
Issue/Submission Date
2019-06-17
Application Number
32201
Indian CDSCO WC-0195
Status
Status - Active
Facility Fees - Paid
DMF Review - Complete
VALID
 
Valid - 2022-07-02
Filing Details
PIRFENIDONE
Pirfenidone
Pirfenidone BP/EP
Issue/Submission Date
2017-10-28
2018-10-11
2019-06-17
See all info for this product

See Less

USDMF

Found

Application Number
32085
Status
Status - Active
Facility Fees - Paid
DMF Review - Complete
Filing Details
QUETIAPINE FUMARATE USP
Issue/Submission Date
2017-10-03
CEP/COS

Found

Application Number
Status
VALID
Filing Details
Quetiapine Fumarate
Issue/Submission Date
2020-01-14
Japanese DMF

Close

Application Number
Status
 
Filing Details
Issue/Submission Date
Written Confirmation

Found

Application Number
Indian CDSCO WC-0195
Status
Valid - 2022-07-02
Filing Details
Quetiapine Fumarate BP/EP/USP
Issue/Submission Date
2019-06-17
Application Number
32085
Indian CDSCO WC-0195
Status
Status - Active
Facility Fees - Paid
DMF Review - Complete
VALID
 
Valid - 2022-07-02
Filing Details
QUETIAPINE FUMARATE USP
Quetiapine Fumarate
Quetiapine Fumarate BP/EP/USP
Issue/Submission Date
2017-10-03
2020-01-14
2019-06-17
See all info for this product

See Less

USDMF

Found

Application Number
31801
Status
Status - Active
Facility Fees - Paid
DMF Review - N/A
Filing Details
LURASIDONE HYDROCHLORIDE
Issue/Submission Date
2017-06-06
CEP/COS

Close

Application Number
Status
Filing Details
Issue/Submission Date
Japanese DMF

Close

Application Number
Status
 
Filing Details
Issue/Submission Date
Written Confirmation

Found

Application Number
Indian CDSCO WC-0195
Status
Valid - 2022-07-02
Filing Details
Lurasidone Hydrochloride IH
Issue/Submission Date
2019-06-17
Application Number
31801
Indian CDSCO WC-0195
Status
Status - Active
Facility Fees - Paid
DMF Review - N/A
 
Valid - 2022-07-02
Filing Details
LURASIDONE HYDROCHLORIDE
Lurasidone Hydrochloride IH
Issue/Submission Date
2017-06-06
2019-06-17
See all info for this product

See Less

USDMF

Found

Application Number
29180
Status
Status - Active
Facility Fees - Paid
DMF Review - Complete
Filing Details
MEMANTINE HYDROCHLORIDE USP
Issue/Submission Date
2015-03-16
CEP/COS

Close

Application Number
Status
Filing Details
Issue/Submission Date
Japanese DMF

Close

Application Number
Status
 
Filing Details
Issue/Submission Date
Written Confirmation

Found

Application Number
Indian CDSCO WC-0195
Status
Valid - 2022-07-02
Filing Details
Memantine Hydrochloride USP
Issue/Submission Date
2019-06-17
Application Number
29180
Indian CDSCO WC-0195
Status
Status - Active
Facility Fees - Paid
DMF Review - Complete
 
Valid - 2022-07-02
Filing Details
MEMANTINE HYDROCHLORIDE USP
Memantine Hydrochloride USP
Issue/Submission Date
2015-03-16
2019-06-17